An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice

Journal of Clinical Investigation

Volumn 114, Issue 10, 2004, Pages 1418-1432

  Mazzone, Massimiliano ^a   Basilico, Cristina ^a   Cavassa, Silvia ^a   Pennacchietti, Selma ^a   Risio, Mauro ^a   Naldini, Luigi ^a,c   Comoglio, Paolo M ^a   Michieli, Paolo ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; PRO SCATTER FACTOR; PROTEIN PRECURSOR; PROTEINASE; SCATTER FACTOR; UNCLASSIFIED DRUG; COLLAGEN; GLUTAMINE; METHIONINE; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN;

AMINO ACID SUBSTITUTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RECEPTOR BINDING; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CARCINOMA; CHEMISTRY; ENZYME ACTIVATION; FEMALE; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; ISOLATION AND PURIFICATION; LENTIVIRINAE; METABOLISM; MITOSIS; NEOPLASM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROTEIN ENGINEERING; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

AMINO ACID SUBSTITUTION; ANIMALS; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; COLLAGEN; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEMALE; GENE THERAPY; GENETIC VECTORS; GLUTAMINE; HEPATOCYTE GROWTH FACTOR; HUMANS; LENTIVIRUS; METHIONINE; MICE; MICE, NUDE; MITOSIS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROTEIN ENGINEERING; PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 85047689927     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22235     Document Type: Article

References (55)

1. Stoker, N., Gherardi, E., Perryman, M., and Grey, J. 1987. Scatter factor is a fibroblast-derived modulator of epithelial cell motility. Nature. 327:239-242.
2. Gherardi, E., Gray, J., Stoker, M., Perryman, M., and Furlong, R. 1989. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. U. S. A. 86:5844-5848.
3. Nakamura, T., Teramoto, H., and Ichihara, A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. 1986. Proc. Natl. Acad. Sci. U. S. A. 83:6489-6493.
4. Zarnegar, R., and Michalopoulos, G. 1989. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 49:3314-3320.
5. Weidner, K.M., et al. 1991. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. U. S. A. 88:7001-7005.
6. Naldini, L., et al. 1991. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 10:2867-2878.
7. Montesano, R., Matsumoto, K., Nakamura, T., and Orci L. 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:901-908.
8. Rubin, J.S., Bottaro, D.P., and Aaronson, S.A. 1993. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim. Biophys. Acta. 1155:357-371.
9. Zarnegar, R., and Michalopoulos, G. 1995. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 129:1177-1180.
10. Tamagnone, L., and Comoglio, P.M. 1997. Control of invasive growth by hepatocyte growth factor (SF) and related scatter factors. Cytokine Growth Factor Rev. 8:129-142.
11. Comoglio, P.M., and Trusolino, L. 2002. Invasive growth: from development to metastasis. J. Clin. Invest. 109:857-862. doi:10.1172/JCI200215392.
12. Trusolino, L., and Comoglio, P.M. 2002. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev. Cancer. 4:289-300.
13. Woolf, A.S., et al. 1995. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J. Cell Biol. 128:171-184.
14. Takayama, H., La Rochelle, W.J., Anver, M., Bockman, D.E., and Merlino, G. 1996. Scatter factor/ hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc. Natl. Acad. Sci. U. S. A. 93:5866-5871.
15. Andermarcher, E., Surani, M., and Gherardi, E. 1996. Co-expression of the SF/HGF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis. Dev. Genet. 18:254-266.
16. Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., and Birchmeier, C. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature. 376:768-771.
17. Schmidt, C., et al. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 373:699-702.
18. Uehara, Y., et al. 1995. Placental defect and embryonal lethality in mice lacking hepathocyte growth factor/scatter factor. Nature. 373:702-705.
19. Huh, C.G., et al. 2004. Hepatocyte growth factor/ c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. U. S. A. 101:4477-4482.
20. Yoshida, S., et al. 2003. Neutralization of hepatocyte growth factor leads to retarded cutaneous wound healing associated with decreased neovascularization and granulation tissue formation. J. Invest. Dermatol. 120:335-343.
21. Galimi, F., et al. 1994. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J. Cell Biol. 127:1743-1754.
22. Birchmeier, C., Birchmeier, W., Gherardi, E., and Vande Woude, G.F. 2003. Met, metastasis, motility, and more. Nat. Rev. Mol. Cell Biol. 4:915-925.
23. Naldini, L., et al. 1992. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11:4825-4833.
24. Naka, D., et al. 1992. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J. Biol. Chem. 267:20114-20119.
25. Kobayashi, T., et al. 1994. Hepatocyte growth factor specifically binds to sulfoglycolipids. J. Biol. Chem. 269:9817-9821.
26. Lyon, M., Deakin, J.A., Mizuno, K., Nakamura, T., and Gallagher J.T. 1994. Interaction of hepatocyte growth factor with heparan-sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem. 269:11216-11223.
27. Zhu, Y., Hojo, Y., Ikeda, U., and Shimada, K. 2000. Production of hepatocyte growth factor during acute myocardial infarction. Heart. 83:450-455.
28. Shiota, G., Umeki, K., Okano, J., and Kawasaki, H. 1995. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. J. Med. 26:295-308.
29. Nakamura, S., Gohda, E., Matsuo, Y., Yamamoto, I., and Minowada, J. 1994. Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patients. Br. J. Haematol. 87:640-642.
30. Miyazawa, K., Shimomura, T., Naka, D., and Kitamura, N. 1994. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J. Biol. Chem. 269:8966-8970.
31. Mizuno, K., Takehara, T., and Nakamura, T. 1992. Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease. Biochem. Biophys. Res. Commun. 189:1631-1638.
32. Peek, M., Moran, P., Mendoza, N., Wickramasinghe, D., and Kirchhofer, D. 2002. Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa. J. Biol. Chem. 277:47804-47809.
33. Shimomura, T., et al. 1993. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J. Biol. Chem. 268:22927-22932.
34. Schmassmann, A., et al. 1997. Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats. Gastroenterology. 113:1858-1872.
35. Jiang, W.G., and Harding, K.G. 1998. Enhancement of wound tissue expansion and angiogenesis by matrix-embedded fibroblast (dermagraft), a role of hepatocyte growth factor/scatter factor. Int. J. Mol. Med. 2:203-210.
36. Sugimura, K., et al. 2001. Production and activation of hepatocyte growth factor in acute renal failure. Ren. Fail. 23:597-603.
37. Aguirre Ghiso, J.A., Alonso, D.F., Farias, E.F., Gomez, D.E., and de Kier Joffe, E.B. 1999. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur. J. Biochem. 263:295-304.
38. Parr, C., Watkins, G., Mansel, R.E., and Jiang, W.G. 2004. The hepatocyte growth factor regulatory factors in human breast cancer. Clin. Cancer Res. 10:202-211.
39. Pennacchietti, S., et al. 2003. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell. 3:347-361.
40. Graham, C.H., Fitzpatrick, T.E., and McCrae, K.R. 1998. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood. 91:3300-3307.
41. Naldini, L., et al. 1995. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J. Biol. Chem. 270:603-611.
42. Cao, B., et al. 2001. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl. Acad. Sci. U. S. A. 98:7443-7448.
43. Matsumoto, K., and Nakamura, T. 2003. NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci. 94:321-327.
44. Michieli, P., et al. 2004. Targeting the tumor and its microenvironment by a dual-function decoy Met receptor. Cancer Cell. 6:61-73.
45. Follenzi, A., Ailles, L.E., Bakovic, S., Geuna, M., and Naldini, L. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25:217-222.
46. Lokker, N.A., et al. 1992. Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J. 11:2503-2510.
47. Bussolino, F., et al. 1992. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119:629-641.
48. Follenzi, A., Sabatino, G., Lombardo, A., Boccaccio, C., and Naldini, L. 2002. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum. Gene Ther. 13:243-260.
49. Matsumoto, K., Kataoka, H., Date, K., and Nakamura, T. 1998. Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses. J. Biol. Chem. 273:22913-22920.
50. Stamos, J., Lazarus, R.A., Yao, X., Kirchhofer, D., and Wiesmann, C. 2004. Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J. 23:2325-2335.
51. Kirchhofer, D., et al. 2004. Structural and functional basis of the serine protease-like HGF beta-chain in Met binding and signaling. J. Biol. Chem. 279:39915-39924.
52. Hartmann, G., et al. 1992. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc. Natl. Acad. Sci. U. S. A. 89:11574-11578.
53. Choong, P.F., and Nadesapillai, A.P. 2003. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis. Clin. Orthop. 415:546-558.
54. Frisch, S.M., and Francis, H. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
55. Vigna, E., and Naldini, L. 2000. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J. Gene Med. 2:308-316.